John Cooke
49Patents
16h-index
49Co-inventors
81Inventor score
Filing activity: Aug 28, 1978 → Aug 5, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5428070A | Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production of activity | Chemistry; Metallurgy | 154 | Expired |
| US5891459A | Enhancement of vascular function by modulation of endogenous nitric oxide production or activity | Chemistry; Metallurgy | 126 | Expired |
| US6117872A | Enhancement of exercise performance by augmenting endogenous nitric oxide production or activity | Human Necessities | 97 | Expired |
| US5861168A | Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury | Human Necessities | 71 | Expired |
| US5025001A | S-nitroso derivatives of ACE inhibitors and the use thereof | Chemistry; Metallurgy | 64 | Expired |
| US5945452A | Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity | Human Necessities | 56 | Expired |
| US6063432A | Arginine or lysine containing fruit healthbar formulation | Emerging Cross-Sectional Technologies | 55 | Expired |
| US6417205B1 | Nicotine in therapeutic angiogenesis and vasculogenesis | Human Necessities | 52 | Expired |
| US5852058A | Intramural delivery of nitric oxide enhancer for inhibiting lesion formation after vascular injury | Human Necessities | 47 | Expired |
| US6646006B2 | Enhancement of vascular function by modulation of endogenous nitric oxide production or activity | Chemistry; Metallurgy | 44 | Expired |
| US6605115B1 | Method and composition for inhibiting cardiovascular cell proliferation | Human Necessities | 29 | Expired |
| US5536723A | S-nitroso derivatives of hydrazinoacetic acids, 1-[(acylthio and (mercapto)-1-oxoalkyl]-1,2,34-Tetrahydroquinoline-2-carboxylic acids and alanyl prolines and isoquinolines | Chemistry; Metallurgy | 27 | Expired |
| US6720340B1 | Nicotine receptor agonists in stem cell and progenitor cell recruitment | Human Necessities | 27 | Expired |
| US5187183A | S-nitroso derivatives of ACE inhibitors and the use thereof | Chemistry; Metallurgy | 22 | Expired |
| US6642208B2 | Enhancement of vascular function by modulation of endogenous nitric oxide production or activity | Chemistry; Metallurgy | 21 | Expired |
| US5356890A | S-nitroso derivatives of ace inhibitors and the use thereof | Chemistry; Metallurgy | 20 | Expired |
| US4210252A | Angleworm storage box | Performing Operations; Transporting | 16 | Expired |
| US7598275B2 | Nicotine in therapeutic angiogenesis and vasculogenesis | Human Necessities | 15 | Active |
| US7452916B2 | Enhancement of vascular function by modulation of endogenous nitric oxide production or activity | Chemistry; Metallurgy | 14 | Expired |
| US8188043B2 | Nicotine in therapeutic angiogenesis and vasculogenesis | Human Necessities | 10 | Active |
| US7045534B2 | Methods of reducing angiogenesis | Human Necessities | 10 | Expired |
| US6337321B1 | Enhancement of vascular function by modulation of endogenous nitric oxide production or activity | Chemistry; Metallurgy | 9 | Expired |
| US6358699B1 | Assay for asymmetrical NG, NG dimethyl-l-arginine | Emerging Cross-Sectional Technologies | 8 | Expired |
| US6896339B2 | Methods and system for controlling latching exhaust valves | Performing Operations; Transporting | 6 | Expired |
| US7611844B2 | Methods for detecting asymmetric dimethylarginine in a biological sample | Emerging Cross-Sectional Technologies | 5 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.